Paracetamol: the potential therapeutic pathways defining its clinical use

Area of Science:

• Pharmacology
• Neuroscience
• Pain Management

Background:

• Paracetamol is a widely used non-narcotic analgesic and antipyretic.
• Its anti-inflammatory effects are limited compared to NSAIDs.
• The exact molecular mechanism of paracetamol remains incompletely understood.

Purpose of the Study:

• To review the possible molecular pathways of paracetamol.
• To elucidate the mechanisms underlying paracetamol's clinical applications.

Main Methods:

• Literature review of existing studies on paracetamol's mechanism of action.
• Analysis of research on cyclooxygenase (COX) pathways, cannabinoid receptors (CB1R, CB2R), transient receptor potential cation channel subfamily member 1 (TRPV1), and serotonin pathways.

Main Results:

• Paracetamol and its metabolite AM404 interact with COX enzymes indirectly via CB1R, CB2R, and TRPV1.
• Paracetamol influences serotonin pathways by increasing release, decreasing metabolism, or blocking reuptake.
• While COX-3 is implicated, it alone does not explain paracetamol's full effects.

Conclusions:

• Paracetamol's analgesic, antinociceptive, and antipyretic properties stem from a complex interplay of multiple signaling pathways.
• Understanding these diverse mechanisms is crucial for optimizing paracetamol's clinical use.